The Phoenix Mills Ltd. (PDF)
Trending Sector
Current IPOs
Closed IPOs
Listed IPOs
IPO Performers
CAGR Calculator
Adani Ports and SEZ
Marksans Pharma Ltd. Share Price
Pharmaceuticals & DrugsMarksans Pharma Ltd. (INR)250.15-0.5 (-0.2%) 
Exchange ScripsBSE524404NSEMARKSANSISININE750C01026
Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks
Trendline of performance -
Marksans Pharma Ltd. Performance
Market performance
Open price249.95
High255.2
Volumes848230
Prev Close250.15
Low244.5
Closing date2025-06-18
Historical performance
1 Year High358.70
3 Year High358.70
5 Year High358.70
1 Year Low157.06
3 Year Low38.60
5 Year Low31.65
Marksans Pharma Ltd. Fundamentals
Company Valuation
Market Cap (₹Cr)
NaN
Face Value (₹)
P/E Ratio
Dividend Yield
N/A
Marksans Pharma Ltd. Investment Returns
1 Year
56.4%
3 Years
492.8%
5 Years
629.3%
10 Years
320.4%
Marksans Pharma Ltd. Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 255.59 | Bearish |
| 10-DMA | 255.46 | Bearish |
| 20-DMA | 254.86 | Bearish |
| 50-DMA | 234.97 | Bullish |
| 100-DMA | 231.58 | Bullish |
| 200-DMA | 262.19 | Bearish |
Shareholding Pattern
| Field | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 | Mar-2024 |
|---|---|---|---|---|---|
| Promoters | 2 | 2 | 2 | 2 | 2 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 2 | 2 | 2 | 2 | 2 |
| Public Investors | 257271 | 259811 | 248843 | 235498 | 254697 |
| Government | --- | --- | --- | --- | --- |
Marksans Pharma Ltd. Financials
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Other Income | 504 | 593 | 419 | 67 |
| Operating Profit | 5090 | 3986 | 3007 | 3463 |
| Interest | 112 | 91 | 84 | 80 |
| Depreciation | 743 | 519 | 448 | 362 |
| Profit Before Tax | 4235 | 3377 | 2475 | 3022 |
| Consolidated Net Profit | 3137 | 2663 | 1846 | 2359 |
| Adjusted EPS | 7 | 6 | 5 | 6 |
Balance Sheet
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Share Capital | 453 | 453 | 409 | 409 |
| Total Reserves | 20197 | 16998 | 10682 | 8456 |
| Minority Interest | 209 | 199 | 207 | 189 |
| Total Non-Current Liabilities | 2052 | 843 | 571 | 237 |
| Total Liabilities | 26810 | 21904 | 16601 | 12280 |
| Capital Work in Progress | 54 | 72 | 7 | 56 |
| Total Assets | 26810 | 21904 | 16601 | 12280 |
Cash Flow
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Cash Flow from Operating Activities | 2304 | 2374 | 993 | 1786 |
| Cash Flow from Investing Activities | -1408 | -2592 | -844 | -448 |
| Cash Flow from Financing Activitie | -687 | 1978 | 795 | -153 |
| Net Cash Inflow / Outflow | 208 | 1760 | 944 | 1185 |
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 36.14.
- 3Y Stock Price CAGR of the stock is 85.1.
- The stock has a beta of 1.3.
- In the last financial year, the company had an EBITDA of ₹5090 Million.
- The company generated revenue of ₹21774 Million in the previous financial year.
Marksans Pharma Ltd.
250.15-0.5 (-0.2%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1584130.2
No. of Shares: 6332.7
Performance:58.4%
P/L: ₹584130.2
Top Gainers
| Symbol | Change% |
|---|---|
| EMIL | 158.37(18%) |
| SILLYMONKS | 18(14%) |
| OPTIEMUS | 684.6(11%) |
| AAKASH | 9.7(11%) |
| PFOCUS | 130.98(10%) |
Similar stocks
Announcing Stock of the Month!
Live video call With Our Agent